<$100M
Funds under one hundred million dollars, typically for niche or targeted investments.
22 Investors with <$100M industry focus

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.
Escalate Capital Partners is a prominent private credit and growth equity investment firm focusing on rapidly growing later-stage companies in the technology, software, services, and healthcare sectors. With a robust investment history, the firm has deployed $1.3 billion to accelerate growth while minimizing dilution for management and equity holders. The firm prides itself on providing stable and tailored capital solutions, backed by an experienced investment team with over 100 years of combined expertise, having invested over $2 billion in more than 500 companies.

SeedFolio is a venture capital firm based in San Diego, focusing on early-stage investments in companies developing novel technologies to conquer disease and clean the planet. The firm aims to generate significant benefits for patients and customers while achieving substantial profits for the company and its investors. SeedFolio employs a rigorous and systematic process to source and select companies with high reward/risk ratios.

The Novartis Venture Fund is dedicated to fostering innovation in the life sciences sector, with a mission to drive significant patient benefits and generate superior returns. The fund invests in biotechnology and biopharmaceutical companies at various stages of growth, managing over USD 750 million in committed capital across more than 40 portfolio companies in North America and Europe. The fund focuses on developing novel therapeutics and platforms to address unmet patient needs globally.

Fannin Innovation Studio is dedicated to developing early-stage pharmaceutical and medical device assets that address vital unmet medical needs. The firm primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators, particularly in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies through preclinical work and engineering up through early clinical trials, aiming to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.
Keiretsu Forum is a global investment community of accredited private equity angel investors, venture capitalists, and corporate/institutional investors. Founded in 2000 by Randy Williams in the San Francisco East Bay, it has grown into a worldwide network with 53 chapters across 4 continents. The forum is renowned for its high-quality, diverse investment opportunities and is ranked as one of the most active venture investors in the USA. Keiretsu Forum emphasizes a holistic approach to investment, fostering interlocking relationships with partners and key resources to offer top-tier deal flow and investment opportunities. The community is also actively involved in social and charitable activities, enhancing its global network of capital, resources, and deal flow.

SternAegis Ventures is the Private Equity Investment Banking Division of Aegis Capital Corp. The firm partners with entrepreneurs and early-stage companies to bring ideas to life, aiming to create brands with long-term investment value. SternAegis adds value through its expertise in capital formation and the introduction of strategic relationships.
Eurazeo is a leading private asset manager in Europe, leveraging a diversified fund offering and a unique network to identify high growth potential companies. The firm is committed to building European champions with global ambitions, focusing on mid-market and growth segments. Eurazeo integrates ESG support into its strategy, aiming to invest in companies that resolve environmental, social, and societal issues, with a goal of achieving net zero carbon by 2040.

MBX Capital is a venture capital firm dedicated to investing in startups that address the root causes of environmental health and healthcare infrastructure challenges. Their mission is to support companies that are tackling the fundamental reasons behind why people get sick, with a focus on improving human health through innovative solutions. MBX Capital is committed to backing leaders who are working to clean up the environment, replace hazardous chemicals, and develop new medicines and diagnostics, while also adapting healthcare infrastructure to meet the rising burden of disease.

Fountain Healthcare Partners is a venture fund that provides risk capital and expertise to ambitious entrepreneurs building outstanding life sciences companies. The firm focuses on a limited number of active portfolio companies to provide more than just capital, offering strategic guidance and support. With a strong presence in both Europe and the United States, Fountain Healthcare Partners invests primarily in the life sciences sector, including specialty pharma, biopharmaceuticals, medical devices, and diagnostics. The firm is committed to responsible investment and aims to facilitate partnerships and build international networks to help its portfolio companies succeed.
EQT is a purpose-driven global investment organization with a 30-year track record of delivering consistent and attractive returns across multiple geographies, sectors, and strategies. The firm is committed to creating value by finding good companies and helping them become the most promising builders of tomorrow. With a global presence, EQT leverages local knowledge and relationships to shape a brighter future, believing that doing good is good business.

Easton Capital is a leading venture capital firm with a focus on healthcare and life sciences. The firm is dedicated to investing in opportunities that can significantly improve healthcare delivery or reduce costs. Easton Capital emphasizes capital-efficient business models, aiming to maximize returns while minimizing risks. The firm boasts a seasoned team with extensive experience in science, technology, clinical affairs, investment, operations, and business development. Easton Capital has a history of successful investments, with several portfolio companies achieving valuations over $1 billion.

Boston Millennia Partners (BMP) is a venture capital firm with a long-standing history of providing growth equity financing to healthcare, business services, and information technology companies. With over 30 years of experience, BMP focuses on building large-scale businesses through strategic consolidation and a 'buy-and-build' approach. The firm leverages its extensive global network and deep industry expertise to support its portfolio companies beyond capital, offering strategic guidance, market analysis, and organizational development.

Sand Hill Angels is a prominent group of 140 Silicon Valley angel investors dedicated to supporting entrepreneurs in elevating their ventures. With over 25 years of experience, they focus on seed-stage investments in disruptive, scalable technologies, providing essential funding, mentorship, and connections. Their extensive network allows entrepreneurs to leverage relationships for growth, making them a key player in the startup ecosystem.

Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI
Medical Technology Enterprise Consortium (MTEC)
The Power of IP: Why It Matters to MTEC and Our Mission
MTEC President highlights intellectual property as essential to protecting innovation, attracting investment, and enabling collaboration. A new partnership with Patenter.io supports members in managing and commercializing IP.
George Mason University
SMART-US Wearable Ultrasound + AI Device for Muscle Force Prediction
AI-powered ultrasound in a wearable—SMART-US delivers lab-grade muscle-force insights anywhere.